ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Aspirin

Also written as “dabigatran with ASA”, “ASA” and “Acetylsalicylic acid (Aspirin, BAY1019036)”.

Its studies are mostly in Coronary Artery Disease · Cardiovascular Diseases · Common Cold · Thrombosis · Peptic Ulcer, led by 28 companies.

Drug pageAspirin: every studyMany companies study it; this page follows only the 70 they lead. All 675 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Dec 15, 200970 company-led studies, 3 open or runningNext primary completion: Mar 10, 2027 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Bayer211 open or runningphase 4since Dec 15, 2009Jul 12, 2007Mar 10, 2027phase 1 · NCT07652723
Boehringer Ingelheimits history only60 open or runningphase 4since Aug 10, 2005Aug 10, 2005none ahead
Bristol-Myers Squibbits history only50 open or runningphase 1since Jul 8, 2009Jul 8, 2009none ahead
Abbottits history only30 open or runningphase 3since Feb 21, 2008Feb 21, 2008none ahead
Boston Scientificits history only30 open or runningphase 4since May 1, 2012Dec 21, 2011none ahead
Johnson & Johnsonits history only30 open or runningphase 4since Dec 2, 2005Dec 2, 2005none ahead
Aralez Pharmaceuticalsits history only20 open or runningphase 1since Feb 27, 2007Feb 27, 2007none ahead
Astellas Pharmaits history only20 open or runningphase 4since May 26, 2016Aug 1, 2011none ahead
Biogenits history only20 open or runningphase 4since Mar 14, 2014Jan 20, 2011none ahead
Chong Kun Dang Pharmaceuticalits history only20 open or runningphase 1since Dec 20, 2010Dec 20, 2010none ahead

Also a collaborator on its studies: Cardialysis, Terumo and ClinLogix.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Bayer only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 4 studies since Jul 12, 2007.

  1. Dec 15, 2009Phase 4 study in Common ColdNCT01033526 · 388 enrolled · Italy
  2. Feb 19, 2010Phase 1 study in PharmacokineticsNCT01072604 · 30 enrolled · United States
  3. Mar 4, 2010Phase 1 study in PharmacokineticsNCT01081353 · 26 enrolled · United States
  4. May 4, 20102 phase 3 studies in Drugs, InvestigationalNCT01117636, NCT01122602
  5. May 17, 20113 phase 4 studiesNCT01465009, NCT01464983, NCT01464944
  6. May 25, 2011Phase 3 study in Common ColdNCT01361399 · 1,088 enrolled · Russian Federation, Ukraine
  7. Jul 27, 2011Phase 3 study in ToothacheNCT01420094 · 510 enrolled · United States
  8. Mar 9, 2012Phase 3 study in HeadacheNCT01552798 · 9 enrolled · United States
  9. Jan 24, 2013Phase 3 study in Coronary Artery DiseaseNCT01776424 · 27,395 enrolled · United States, Argentina, Australia and more
  10. Mar 14, 2015Phase 1 study in Pharmacology, ClinicalNCT02394093 · 30 enrolled · United States
  11. Feb 15, 2017Phase 1 study in PainNCT03056703 · 38 enrolled · United States
  12. Jul 16, 2017Phase 1 study in Moderate PainNCT03225352 · 12 enrolled · United Kingdom
  13. Oct 22, 2024Phase 1 study in BioequivalenceNCT06655194 · 38 enrolled · Mexico
  14. Jun 8, 2026Phase 1 study in Drug-drug InteractionNCT07652723 · 16 planned · United States

Ahead

  1. Mar 10, 2027Primary completion: phase 1 study in Drug-drug InteractionNCT07652723

TargetBeta

PTGS1 →PTGS2 →read by rule
“Cyclooxygenase inhibitor”ChEMBL 37, by rule

Other programs on the same two targets

ProgramCompanyFurthest phaseStudies
AcetaminophenruleJohnson & Johnsonphase 4136
IbuprofenrulePfizerphase 4113
dexketoprofenruleMenarini Groupphase 48
SulfasalazineruleBristol-Myers Squibbphase 47
dexibuprofenruleaponia-laboratories-incphase 46
BenzydamineruleAngelini Pharmaphase 44
DipyroneruleHypera Pharmaphase 44
PiroxicamruleTaisho Pharmaceuticalphase 44
FlurbiprofenruleGlaxoSmithKlinephase 312

Studies

All 21 Bayer leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07652723Drug-drug Interaction · United States1RecruitingMar 10, 202716
NCT06655194Bioequivalence · Mexico1CompletedApr 6, 202538
NCT03225352Moderate Pain · United Kingdom1CompletedOct 7, 201712
NCT03056703Pain · United States1CompletedMar 201438
NCT02394093Pharmacology, Clinical · United States1CompletedMar 201530
NCT01776424Coronary Artery Disease · United States, Argentina, Australia and more3CompletedJul 21, 201727,395
NCT01552798Headache · United States3TerminatedJun 4, 20129
NCT01420094Toothache · United States3CompletedSep 8, 2011510
NCT01361399Common Cold · Russian Federation, Ukraine3CompletedMay 28, 20051,088
NCT01465009Common Cold · United Kingdom4Completed508
NCT01464983Headache · United Kingdom4Completed1,115
NCT01464944Respiratory Tract Infections · Russian Federation, Ukraine4Completed392
NCT01122602Drugs, Investigational · United States3CompletedJul 29, 2010500
NCT01117636Drugs, Investigational · United States3CompletedJul 7, 2010514
NCT01081353Pharmacokinetics · United States1CompletedMar 201026
NCT01072604Pharmacokinetics · United States1CompletedAug 200930
NCT01033526Common Cold · Italy4Completed388
NCT01062360Common Cold · United States, Italy, Poland and more3CompletedMay 14, 20071,016
NCT01028079Low Back Pain · Germany, United Kingdom3Completed338
NCT00963443Common Cold · United Kingdom3CompletedMar 2012833
NCT00501059Stroke · United States, Germany, Ireland and more3CompletedNov 15, 201612,546

How it is read

Names in the registry

  • “Aspirin”, 25 entries
  • “dabigatran with ASA”, 6 entries
  • “ASA”, 5 entries
  • “Acetylsalicylic acid (Aspirin, BAY1019036)”, 5 entries
  • “Acetylsalicylic acid (Aspirin, BAYE4465)”, 5 entries

Codes read as this program: BAY1019036.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.